- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05157919
Mobile App to Promote Family Caregiver Engagement in the Intensive Care Unit (ICU-CARE)
January 2, 2024 updated by: University of Nebraska
Evaluation of a Mobile App to Promote Family Caregiver Engagement in Symptom Assessment and Management During Mechanical Ventilation in the Intensive Care Unit
The purpose of this randomized controlled pilot trial is to develop and test mobile app, Intensive Care Unit-Caregiver Activation Response, and Engagement (ICU-CARE).
ICU-CARE provides a simulated learning environment to encourage family caregivers of mechanically ventilated patients to assess two patient symptoms, thirst and anxiety, and perform specific nonpharmacologic comfort measures to help alleviate patient symptom burden.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Critical care guidelines call for the liberal inclusion of family caregivers into bedside care, but despite convincing evidence that active family participation improves the patient and family experience as well as safety, quality, and delivery of care, critical care nurses have few evidence-based strategies to engage family caregivers as active participants in the provision of care in the intensive care unit (ICU).
The broad objective of this proposal is to develop and test a mobile app, Intensive Care Unit-Caregiver Activation Response and Engagement [ICU-CARE].
ICU-CARE provides a simulated learning environment that incorporates established motivational learning theories to encourage family caregivers of mechanically ventilated patients to assess two patient symptoms, thirst and anxiety, and perform specific nonpharmacologic symptom management techniques to help alleviate the patient's symptom burden.
This project, guided by the Individual and Family Self-Management Theory, aims to (1) Establish the feasibility and acceptability of the ICU-CARE intervention for family caregivers enrolled in the experimental arm; and (2) Determine the influence of the ICU-CARE intervention on the caregiver process characteristics, proximal caregiving outcomes, and distal caregiving outcomes as compared to family caregivers enrolled in the control arm.
To address these study aims, a convenience sample of 60 family caregivers of mechanically ventilated patients will be recruited into this randomized controlled pilot trial.
30 participants will be enrolled to the control group which will receive usual care with routine caregiver support practices.
Intervention participants (n=30) will be enrolled to an experimental condition ICU-CARE, that will consist of a theoretically grounded mobile app program to promote caregiver engagement in symptom assessment and management in the ICU.
This project will help further define the scope, extent, and nature of patient and family engagement in the ICU, and if proven feasible, our intervention holds the potential to shift the ICU nursing practice paradigm by integrating family caregivers as dynamic partners in ICU care.
Study Type
Interventional
Enrollment (Actual)
18
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Nebraska
-
Omaha, Nebraska, United States, 68105
- Nebraska Medicine
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
19 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
Adult Caregivers of mechanically ventilated ICU patients who are:
- Age 19 or older
- Able to understand English
- Able and willing to use the hospital-provided tablet devices
- Can view images on a screen and hear audio through a standard headset
- Have basic reading skills and the ability to read aloud
Critically ill patients in the ICU who are:
- Age 19 or older
- Mechanically ventilated
- Expected to require> 72 consecutive hours of mechanical ventilation during their ICU stay
- Calm, cooperative (a Richmond Agitation-Sedation Scale score between -5 and +1)
- Able to reliably report symptoms of thirst and anxiety per nursing assessment
- Have no documented hearing deficits
- Have a designated caregiver who visits frequently (daily for a minimum of 1 hour)
Exclusion Criteria:
Adult Caregivers of mechanically ventilated ICU patients who are:
- Caregivers of patients who are not currently undergoing mechanical ventilation
- Caregivers of patients who are not calm, cooperative (a Richmond Agitation- - Sedation Scale score between +2 and +4),
- Caregivers of patients who cannot reliably report symptoms of thirst and anxiety
- Caregivers of patients who have a documented hearing deficit.
- Caregivers who do not visit the patient frequently (at least once per day for a minimum of 1 hour as described by nursing staff)
Critically ill patients in the ICU who are:
- Recovering from any of the following surgeries: Glossectomy, Maxillectomy, Neck Dissection, Facial/neck flap
- Receiving aggressive ventilator support such as positive end expiratory pressure> 15cm of water, prone ventilation
- Not alert per nursing assessment (Richmond Agitation-Sedation Scale Score +2 or greater)
- Severe cognition or communication problems (i.e. coma as the main reason for intubation, dementia, severe delirium)
- Deafness
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Factorial Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Control
Usual care continues.
The caregiver will not get to use the app.
The caregiver will be asked daily measures and the patient will be asked about thirst and anxiety daily when the patient is awake enough to answer these questions.
The caregiver will be asked questions at 3 different times: Day 1, 24-48 hours after enrollment, and 2-4 weeks after the patient is discharged from the ICU.
|
|
|
Experimental: Intervention with App
The caregiver gets access to use the app.
Each day, investigators will ask the patient to rate their thirst and anxiety and the caregiver to answer daily measures through the application.
The caregiver will be asked questions at 3 different times: Day 1, 24-48 hours after enrollment, and 2-4 weeks after the patient is discharged from the ICU.
The caregiver will be taught how to use the app.
The caregiver will be given the supplies that the caregiver needs to perform the symptom management intervention.
Investigators will ask the caregiver to use the app at least once a day, but the caregiver can use it as much as desired while the patient is in the ICU.
|
The mobile app intervention, ICU-CARE, will consist of 3 separate education modules, each approximately 5-7 minutes in length: (Module #1) ICU orientation, (Module #2) Symptom Assessment, (Module #3) Symptom Management
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Enrollment Feasibility of ICU-CARE
Time Frame: Through study completion, estimated 3 years.
|
Total subjects screened, approached, consented and refused
|
Through study completion, estimated 3 years.
|
|
Sustainability of ICU-CARE enrollment
Time Frame: Through study completion, estimated 3 years.
|
Differential attrition rates - the number of subjects in each group that complete all study follow-up measures
|
Through study completion, estimated 3 years.
|
|
Dosage of ICU-CARE
Time Frame: Through study completion, estimated 3 years.
|
Number of doses of the intervention per participant
|
Through study completion, estimated 3 years.
|
|
Acceptability of ICU-CARE
Time Frame: Through study completion, estimated 3 years.
|
Total score of a modified version of the Educational Material Acceptability Instrument.
Minimum Score = 11; Maximum Score = 55.
Higher score indicates greater acceptance.
|
Through study completion, estimated 3 years.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Influence of ICU-CARE on Caregiver Process Characteristics - Caregiver Activation
Time Frame: At study enrollment, 24-48 hours after study enrollment, and 2-4 weeks after ICU discharge
|
Caregiver activation as measured by Patient Activation Measure for Family Caregivers (CG-PAM).
Minimum score = 1; Maximum Score = 4. Higher score indicates greater activation.
|
At study enrollment, 24-48 hours after study enrollment, and 2-4 weeks after ICU discharge
|
|
Influence of ICU-CARE on Caregiver Process Characteristics - Caregiver Self-efficacy
Time Frame: At study enrollment, 24-48 hours after study enrollment, and 2-4 weeks after ICU discharge
|
Caregiver self-efficacy as measured by the Caregiver Self-Efficacy Scale (CaSES).
Scale contains four sub-scales that are scored separately.
Minimum Score =1; Maximal Score = 5.
Higher scores indicate greater self-efficacy.
|
At study enrollment, 24-48 hours after study enrollment, and 2-4 weeks after ICU discharge
|
|
Influence of ICU-CARE on Caregiver Process Characteristics - Caregiver Preparedness
Time Frame: At study enrollment, 24-48 hours after study enrollment, and 2-4 weeks after ICU discharge
|
Caregiver Preparedness as measured by the Preparedness for Caregiving Scale (Prep Scale).
Minimum score = 0; Maximum score = 32.
The higher the score the more prepared the caregiver feels for caregiving.
|
At study enrollment, 24-48 hours after study enrollment, and 2-4 weeks after ICU discharge
|
|
Influence of ICU-CARE on Proximal Caregiving Outcomes - Symptom Assessment
Time Frame: Once every 24 hours from the date the patient is enrolled in the trial to the date the patient is discharged from the ICU, an average of 2 weeks.
|
Rate of symptom assessment behaviors - the number of times in a 24 hour period that the subject records a patient symptom assessment in the ICU-CARE app
|
Once every 24 hours from the date the patient is enrolled in the trial to the date the patient is discharged from the ICU, an average of 2 weeks.
|
|
Influence of ICU-CARE on Proximal Caregiving Outcomes - Symptom Management
Time Frame: Once every 24 hours from the date the patient is enrolled in the trial to the date the patient is discharged from the ICU, an average of 2 weeks.
|
Rate of symptom management behaviors - the number of times in a 24 hour period that the subject records a patient symptom management technique in the ICU-CARE app
|
Once every 24 hours from the date the patient is enrolled in the trial to the date the patient is discharged from the ICU, an average of 2 weeks.
|
|
Influence of ICU-CARE on Proximal Caregiving Outcomes - Caregiver Anxiety
Time Frame: Once every 24 hours from the date the patient is enrolled in the trial to the date the patient is discharged from the ICU, an average of 2 weeks.
|
Caregiver anxiety as measured by the State-Trait Anxiety Inventory (STAI-State).
Minimum score = 0; Maximum score = 6.
Higher scores indicate greater anxiety.
|
Once every 24 hours from the date the patient is enrolled in the trial to the date the patient is discharged from the ICU, an average of 2 weeks.
|
|
Influence of ICU-CARE on Proximal Caregiving Outcomes - Patient Thirst
Time Frame: Once every 24 hours from the date the patient is enrolled in the trial to the date the patient is discharged from the ICU, an average of 2 weeks.
|
Patient thirst as measured by a 0-100 visual analogue scale for thirst (VAS-Thirst)
|
Once every 24 hours from the date the patient is enrolled in the trial to the date the patient is discharged from the ICU, an average of 2 weeks.
|
|
Influence of ICU-CARE on Proximal Caregiving Outcomes - Patient Anxiety
Time Frame: Once every 24 hours from the date the patient is enrolled in the trial to the date the patient is discharged from the ICU, an average of 2 weeks.
|
Patient anxiety as measured by a 0-100 visual analogue scale for anxiety (VAS-Anxiety)
|
Once every 24 hours from the date the patient is enrolled in the trial to the date the patient is discharged from the ICU, an average of 2 weeks.
|
|
Influence of ICU-CARE on Distal Caregiving Outcomes - Caregiver Global Health Status
Time Frame: At study enrollment and 2-4 weeks after ICU discharge
|
Caregiver Global Health Status as measured by the Patient-Reported Outcome Measure (PROMIS-10).
5 questions each on 2 (1-5) subscales (Global Physical Health, Global Mental Health).
Once every 24 hours from the date the patient is enrolled in the trial to the date the patient is discharged from the ICU, an average of 2 weeks.
Higher scores indicate a healthier patient.
|
At study enrollment and 2-4 weeks after ICU discharge
|
|
Influence of ICU-CARE on Distal Caregiving Outcomes - Caregiver Anxiety & Depressive Symptoms
Time Frame: At study enrollment and 2-4 weeks after ICU discharge
|
Caregiver anxiety and depressive symptoms as measured by the Hospital Anxiety and Depression Scale (HADS).
Two sub-scales (Anxiety & Depression) scored separately.
Minimum Score = 0; Maximum Score = 21.
Higher score = higher anxiety and/or depression.
|
At study enrollment and 2-4 weeks after ICU discharge
|
|
Influence of ICU-CARE on Distal Caregiving Outcomes - Caregiver Satisfaction
Time Frame: At study enrollment and 2-4 weeks after ICU discharge
|
Caregiver satisfaction as measured by the Critical Care Family Satisfaction Survey (CCFSS).
Minimum Score = 5; Maximum score = 25.
Higher scores indicate greater satisfaction.
|
At study enrollment and 2-4 weeks after ICU discharge
|
|
Influence of ICU-CARE on Distal Caregiving Outcomes - Caregiver ICU Experience
Time Frame: At study enrollment and 2-4 weeks after ICU discharge
|
Overall impact of ICU experience for caregivers as measured by the Impact of Events Scale-Revised.
Minimum Score = 0; Maximum Score = 88.
Higher score indicates great impact of life event.
|
At study enrollment and 2-4 weeks after ICU discharge
|
|
Influence of ICU-CARE on Distal Caregiving Outcomes - Patient Agitation
Time Frame: Once every 24 hours from the date the patient is enrolled in the trial to the date the patient is discharged from the ICU, an average of 2 weeks.
|
Nurse documentation of patient agitation in the electronic health record
|
Once every 24 hours from the date the patient is enrolled in the trial to the date the patient is discharged from the ICU, an average of 2 weeks.
|
|
Influence of ICU-CARE on Distal Caregiving Outcomes - Patient Pain
Time Frame: Once every 24 hours from the date the patient is enrolled in the trial to the date the patient is discharged from the ICU, an average of 2 weeks.
|
Nurse documentation of patient pain in the electronic health record
|
Once every 24 hours from the date the patient is enrolled in the trial to the date the patient is discharged from the ICU, an average of 2 weeks.
|
|
Influence of ICU-CARE on Distal Caregiving Outcomes - Duration of Ventilation
Time Frame: Once every 24 hours from the date the patient is enrolled in the trial to the date the patient is discharged from the ICU, an average of 2 weeks.
|
Duration of mechanical ventilation
|
Once every 24 hours from the date the patient is enrolled in the trial to the date the patient is discharged from the ICU, an average of 2 weeks.
|
|
Influence of ICU-CARE on Distal Caregiving Outcomes - Sedative Exposure
Time Frame: Through study completion, estimated 3 years.
|
Sedative exposure (sedation intensity and sedation frequency)
|
Through study completion, estimated 3 years.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Breanna D Hetland, PhD, University of Nebraska
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 6, 2020
Primary Completion (Actual)
June 1, 2022
Study Completion (Actual)
June 1, 2022
Study Registration Dates
First Submitted
July 16, 2021
First Submitted That Met QC Criteria
December 1, 2021
First Posted (Actual)
December 15, 2021
Study Record Updates
Last Update Posted (Estimated)
January 3, 2024
Last Update Submitted That Met QC Criteria
January 2, 2024
Last Verified
January 1, 2024
More Information
Terms related to this study
Other Study ID Numbers
- 0625-17-EP
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Mobile Applications
-
University Grenoble AlpsCompletedMobile Applications | Mobile HealthFrance
-
Universitaire Ziekenhuizen KU LeuvenEnrolling by invitationMobile ApplicationsBelgium
-
National University of MalaysiaCompletedMobile ApplicationsMalaysia
-
University College DublinCompletedExercise | Mobile ApplicationsIreland
-
Vicente Lorenzo-Zúñiga GarcíaCompletedMobile Applications | Cathartics
-
Istanbul University - CerrahpasaCompletedCancer | Mobile Applications | Chemotherapeutic ToxicityTurkey
-
Ondokuz Mayıs UniversityNot yet recruitingMobile Applications | Organ Transplantation | NursingTurkey (Türkiye)
-
Universitair Ziekenhuis BrusselUnknown
-
University of TorontoUnknownMobile Applications | Diet, Healthy | Behavior, HealthCanada
-
University of California, Los AngelesCompletedContraception | Mobile Applications | Contraception BehaviorUnited States
Clinical Trials on ICU-Care
-
Charite University, Berlin, GermanyLudwig-Maximilians - University of Munich; Technische Universität Berlin; BARMER and other collaboratorsCompleted
-
University Hospital of CologneAlbert Einstein College of Medicine; Monash University; The Alfred; Johann Wolfgang...Recruiting
-
University of GöttingenUniversity Medical Center GoettingenUnknownSystemic Lupus Erythematosus | Vasculitis | MyositisGermany
-
China Medical University HospitalRecruitingRespiratory Failure | Morality | Delayed Gastric Emptying | Organ Failure, Multiple | IndigestionTaiwan
-
Christian SchulzeCompleted
-
University Hospital, Clermont-FerrandCompleted
-
Saint Savvas Anticancer HospitalUnknownPostoperative Care | Intensive CareGreece
-
Wake Forest University Health SciencesNational Institute on Aging (NIA)CompletedCritical Illness | Cognitive Impairment | Dementia | Cognitive Impairment, Mild | Post ICU SyndromeUnited States
-
University of PittsburghCompletedDepression | AnxietyUnited States